Work

CRS free T cell therapy: T cell membrane anchored and tumor targeted IL12 (ATTIL12)-T cell therapy eliminates large tumors, overcomes heterogeneity, and avoids adverse effects

Year: 2020

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.204.supp.239.1

Authors: Jiemiao Hu, Wendong Zhang, Xueqing Xia, Qing Yang, Yuhui Chen, Natalie W Fowlkes, John Andrew Livingston, Zhongting Zhang, Kris M Mahadeo, Jonathan B Gill, Gianpietro Dotti, Scott Kopetz, Richard Gorlick, Shulin Li

Institutions: The University of Texas MD Anderson Cancer Center, Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4313373530

Cites:

Cited by:

Related to: 10